News Conference News AHA 2017 Methamphetamine Use Growing More Common in Veterans With Heart Failure Todd Neale November 24, 2017
Presentation TCT 2017 State-of-the-Art: Latest Innovations in Durable LVADs Presenter: Ulrich P. Jorde, Michael Mooney, Hiroo Takayama, Nir Uriel November 01, 2017
Presentation TCT 2017 Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials? Presenter: James E. Udelson November 01, 2017
Presentation TCT 2017 Editorial Perspective: The Evolving Role of LVAD in Interventional HF Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Ileana L. Pina October 31, 2017
Presentation TCT 2017 The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM Presenter: Morton J. Kern, Sherif F. Nagueh October 30, 2017
News Daily News FDA Grants HeartWare LVAD a Destination Therapy Indication Todd Neale September 28, 2017
News Industry News Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients July 20, 2017
News Daily News Cardiac Recovery Possible in Patients With Cardiomyopathy Related to Methamphetamine Abuse Todd Neale May 30, 2017
News Daily News HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems Todd Neale May 24, 2017
News Daily News Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis Alison Palkhivala May 23, 2017
News Conference News Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial Todd Neale April 07, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines Todd Neale February 03, 2017